P. Batard

发表

Fluorescent proteins in animal cells for process development: Optimization of sodium butyrate treatment as an example

F. Wurm, L. Hunt, P. Batard, 2002, Biotechnology and bioengineering.

The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells.

J. Partanen, J. Hatzfeld, K. Alitalo, 1996, Blood.

IL-3, GM-CSF and CSF-1 modulate c-fms mRNA more rapidly in human early monocytic progenitors than in mature or transformed monocytic cells.

J. Hatzfeld, A. Hatzfeld, A. Cardoso, 1996, Journal of cell science.

Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells.

D. Speiser, P. Romero, M. Pittet, 2003, Journal of Immunology.

Early CD34high cells can be separated into KIThigh cells in which transforming growth factor-beta (TGF-beta) downmodulates c-kit and KITlow cells in which anti-TGF-beta upmodulates c-kit.

B. Lim, J. Hatzfeld, A. Hatzfeld, 1995, Blood.

High proliferative potential-quiescent cells: a working model to study primitive quiescent hematopoietic cells.

N. Fortunel, J. Hatzfeld, A. Hatzfeld, 1998, Journal of cell science.

Use of phycoerythrin and allophycocyanin for fluorescence resonance energy transfer analyzed by flow cytometry: advantages and limitations.

P. Romero, P. Batard, J. Cerottini, 2002, Cytometry.

Antigenicity and immunogenicity of Melan‐A/MART‐1 derived peptides as targets for tumor reactive CTL in human melanoma

D. Speiser, P. Romero, N. Rufer, 2002, Immunological reviews.

In vivo activation of melanoma‐specific CD8+ T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus‐specific T cells

D. Speiser, P. Romero, M. Pittet, 2002, European journal of immunology.

replicative history and partial effector functions Ex vivo characterization of human CD8+ T subsets with distinct

P. Corthésy, M. Pittet, S. Leyvraz, 2013 .

Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cells.

D. Speiser, P. Romero, D. Peterson, 2006, Journal of immunological methods.

Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.

D. Speiser, P. Romero, M. Pittet, 2004, Cancer immunity.

Communicated by : LJ Old Ex vivo detectable activation of MelanA-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA

D. Speiser, P. Romero, M. Pittet, 2004 .

Disease-driven T cell activation predicts immune responses to vaccination against melanoma.

D. Speiser, P. Romero, P. Batard, 2003, Cancer immunity.

Functional Avidity of Tumor Antigen-Specific CTL Recognition Directly Correlates with the Stability of MHC/Peptide Multimer Binding to TCR1

D. Speiser, P. Romero, D. Valmori, 2002, The Journal of Immunology.

This information is current as to TCR Stability of MHC / Peptide Multimer Binding theCTL Recognition Directly Correlates with Functional Avidity of Tumor Antigen-Specific Romero and Danila

D. Speiser, P. Romero, D. Valmori, 2002 .

Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity.

D. Speiser, P. Romero, D. Valmori, 2001, Cancer research.

Antitumor Activity Avidity-specific Cytolytic T Lymphocytes Show Superior : High 262 − 254 Heterogeneous T-Cell Response to MAGE-A 10 Updated Version

D. Speiser, P. Romero, D. Valmori, 2001 .

Specific dose-response effects of TGF-beta1 on developmentally distinct hematopoietic stem/progenitor cells from human umbilical cord blood.

N. Fortunel, J. Hatzfeld, A. Hatzfeld, 2000, The hematology journal : the official journal of the European Haematology Association.

Intranasal treatment with ovalbumin but not the major T cell epitope ovalbumin 323–339 generates interleukin‐10 secreting T cells and results in the induction of allergen systemic tolerance

F. Spertini, C. Barbey, P. Batard, 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

That Can Home to Nonlymphoid Tissues Human Thymus Exports Naive CD8 T Cells

D. Speiser, P. Romero, N. Rufer, 2004 .

An improved panning technique for the selection of CD34+ human bone marrow hematopoietic cells with high recovery of early progenitors.

J. Hatzfeld, A. Hatzfeld, A. Cardoso, 1995, Experimental hematology.

Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults.

J. Hatzfeld, A. Hatzfeld, E. Brown, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Increased stable retroviral gene transfer in early hematopoietic progenitors released from quiescence.

F. Taieb, J. Hatzfeld, A. Hatzfeld, 1996, Human gene therapy.

Human umbilical cord blood CD34+ cell purification with high yield of early progenitors.

J. Hatzfeld, A. Hatzfeld, J. Lévesque, 1993, Journal of hematotherapy.

Transient Gene Expression: A Novel Mammalian Cell-Based Technology for Recombinant Protein Production

F. Wurm, J. Girard, D. Hacker, 2003 .

The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells.

D. Speiser, P. Romero, M. Colonna, 2001, Journal of immunology.

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.

A. Mackensen, D. Speiser, P. Romero, 2004, Cancer research.

Transfer of high copy number plasmid into mammalian cells by calcium phosphate transfection.

F. Wurm, P. Batard, M. Jordan, 2001, Gene.

S-phase synchronized CHO cells show elevated transfection efficiency and expression using CaPi

Frédéric Grosjean, Florian M. Wurm, Martin Jordan, 2004, Cytotechnology.

The Activatory Receptor 2B4 Is Expressed In Vivo by Human CD8+ Effector αβ T Cells1

D. Speiser, P. Romero, M. Colonna, 2001, The Journal of Immunology.

Release from Quiescence of Primitive Human Hematopoietic Stem/Progenitor Cells by Blocking Their Cell‐Surface TGF‐β Type II Receptor in a Short‐Term In Vitro Assay

N. Fortunel, J. Hatzfeld, A. Hatzfeld, 2000, Stem cells.

TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation.

N. Fortunel, J. Hatzfeld, A. Hatzfeld, 2000, Journal of cell science.

Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions.

P. Corthésy, P. Romero, N. Rufer, 2003, Blood.

Thymic Selection Generates a Large T Cell Pool Recognizing a Self-Peptide in Humans

Danila Valmori, Pedro Romero, Daniel E. Speiser, 2002, The Journal of experimental medicine.

α3 Domain Mutants of Peptide/MHC Class I Multimers Allow the Selective Isolation of High Avidity Tumor-Reactive CD8 T Cells1

D. Speiser, P. Romero, M. Pittet, 2003, The Journal of Immunology.

Human Thymus Exports Naive CD8 T Cells That Can Home to Nonlymphoid Tissues1

D. Speiser, P. Romero, N. Rufer, 2004, The Journal of Immunology.

Purification and release from quiescence of umbilical cord blood early progenitors reveal their potential to engraft adults.

J. Hatzfeld, A. Hatzfeld, J. Lévesque, 1994, Blood cells.

Inhibition of autocrine TGF-ß in CD34+ human progenitor cells reveals their potentiality to engraft adults and improves gene transfer efficiency

J. Hatzfeld, A. Hatzfeld, A. Cardoso, 1996 .

Leukocytes Discrimination by Impedance Spectroscopy Flow Cytometry

S. Gawad, P. Renaud, P. Batard, 2002 .